8:00AM - 9:30AM PDT Los Angeles Convention Center, 409AB
AATS ERAS® Cardiac Conclave: Turn-Key Order Sets – Implementation of ERAS
V. Seenu Reddy, Centennial TriStar
Dr. V. Seenu Reddy graduated magna cum laude from Amherst College and obtained his Medical Degree with Honors from The University of Alabama. He completed a residency in General Surgery and a Research Fellowship in Cardiac Surgery at Vanderbilt University. His Cardiothoracic training was at Emory University with additional expertise in Endovascular and Minimally Invasive Surgery. Dr. Reddy received an MBA with Honors from Vanderbilt University Owen School of Management. He was previously on the faculty of the University of TX San Antonio as Dir. of Emerging Technology, Dir. of Thoracic Aortic Surgery and Associate Prof of Surgery. He is Board Certified in Surgery and Thoracic Surgery. In the community, Dr. Reddy is active with the American Heart Association, served as Board Chair and Past President and of the Nashville Academy of Med, and is a past President of the Nashville Surgical Society. He also serves his specialty through Task Forces in the Southern Thoracic Surgical Association, and Society of Thoracic Surgeons and the American Association of Thoracic Surgery. He has previously served as Clinical Associate Professor of Surgery at Vanderbilt and continues to serve on the faculty for their Perfusion School. He is a Fellow in the American College of Surgeons and American College of Cardiology. Dr. Reddy is engaged in research and has over 12 book chapters, over 30 abstracts and 45 publications in peer reviewed journals. He is a reviewer for The Annals of Thoracic Surgery & JTCVS. He is a consultant to a variety of startup companies and works with Harpeth Capital, Jumpstart and FCA Venture Partners in Nashville. He is on the Memorial Foundation Board. At TriStar Centennial he serves as co-Director of the Structural Heart Program and Director of Cardiac Surgical Outreach the Medical Executive Committee. He is a National Medical Director for HCA’s Cardiovascular Service Line. Dr. Reddy is married and has two children and enjoys boating, hiking and golf.
Daniel Engelman, Baystate Medical Center
Dr. Daniel Engelman is a cardiac surgeon and Medical Director of the Heart, Vascular and Critical Care Unit and inpatient surgical services at Baystate Medical Center. He is a Professor of Surgery and a Professor of Population Science & Healthcare Delivery at The University of Massachusetts Chan-Baystate, School of Medicine. He started the Enhanced Recovery After Cardiac Surgery (ERAS® Cardiac) Collaborative to internationally standardize perioperative best practices and publish the first consensus guidelines.
He has organized perioperative symposium at every major international surgical meeting. He is the Senior Editor for Perioperative Care for the Annals of Thoracic Surgery and serves on the Editorial Board of the Journal Thoracic and Cardiovascular Surgery. He is also the President of the Massachusetts Society of Thoracic Surgeons and serves on multiple Statewide Oversight committees. Dr. Engelman participates on five workforces for the Society of Thoracic Surgeons and the American Association of Thoracic Surgery. He has published over 100 peer-reviewed publications and participates on two international taskforces (ADQI and KDIGO) standardizing approaches for the prevention of postoperative acute kidney injury. He travels extensively lecturing on advances in critical care medicine, healthcare informatics and finance, multimodal analgesia, and enhanced recovery after cardiac surgery.
In 2016 Dr. Engelman was named the National ACS/STS Health Policy Scholar. He is a graduate of the Executive Leadership Program in Health Policy and Management at The Heller School of Brandeis University. He was a Research Fellow at the University of Connecticut School of Medicine. Dr. Engelman received his clinical training in cardiothoracic surgery at Harvard’s Brigham and Women’s Hospital and Boston Children’s Hospital. He received his B.A. with honors from the University of Pennsylvania and M.D. from the New York University School of Medicine.
Sameer Hirji, Brigham and Women's Hospital
Dr. Hirji is a clinical fellow in the Joint 4/3 General and Cardiothoracic Surgery Program at Brigham and Women's Hospital, Harvard Medical School.
Alexander Gregory, Foothills Medical Centre
Dr. Gregory is a cardiovascular anesthesiologist and assistant professor in the Department of Anesthesiology, Perioperative and Pain Medicine, and Libin Cardiovascular Institute, at the Cumming School of Medicine, University of Calgary. After completion of his BSc at Cornell University (2002), he obtained his medical degree (2007), FRCPC training in anesthesiology (2012) at the University of Calgary, and fellowship in cardiothoracic anesthesiology at the University of Pennsylvania (2013). Institutional academic roles include Director of Cardiovascular Anesthesiology Research, Clinical Lead for Thoracic Aortic Surgery, as well as Program Supervisor for both the University of Calgary Cardiovascular Anesthesia and Perioperative Ultrasound Fellowship Programs. Research interests include enhanced recovery, patient reported outcomes, patient blood management, and aortic biomechanics. He has been involved in several multi-center clinical trials developed through the Peri-operative Anesthesiology Clinical Trials (PACT) and Cardio-Link Clinical Trials groups. Memberships include both the Society of Cardiovascular Anesthesiologists’ (SCA) and Canadian Anesthesiologoists’ Society (CAS), as well as an Executive Board Member of the ERAS Cardiac Society.
8:00AM - 9:30AM PDT Los Angeles Convention Center, 515B
Evolving Controversies in Acute Type A Dissection
Ourania Preventza, University of Virginia
Ourania Preventza is Professor of Surgery with tenure at the Department of Surgery, University of Virginia, and Chief of Cardiothoracic Surgery . In addition , Dr Preventza is the Co- Director of the Cardiovascular Service Line at University of Virginia Health. She is also adjunct Professor of Baylor College of Medicine, in Houston and Associate Professional Staff at the Texas Heart Institute, in Houston. Dr Preventza is triple Boarded ,American Board of Surgery, American Board of Surgery (Surgical Critical Care) amd American Board of Thoracic Surgery.She is the President of the International Society of Endovascular Specialists 2021-2023( ISEVS). previous leader of Adult Cardiac Surgery within the Women in Thoracic Surgery, immediate Past Program Committee Chair of the Southern Thoracic Surgical Association and Past Program Commitee co -Chair for the adult Cardiac Surgery during the annual meeting of AATS. Dr Preventza is a holder of management and business administration degree on Health Care leadership from Brandeis University in Boston. Her interest includes education, health outcomes research, social determinamts of health, aortic surgery and structural heart valve surgery.
Douglas Johnston, Cleveland Clinic
Dr Johnston received his undergraduate degree in Anthropology and Classics from Dartmouth College, and subsequently his MD from Harvard Medical School where he was a Harvard National Scholar. He completed general surgery training at the Massachusetts General Hospital, and cardiothoracic surgery training at the Cleveland Clinic, where he joined the staff in 2008. He currently serves as Vice Chairman of the Department of Thoracic and Cardiovascular Surgery at Cleveland Clinic Dr Johnston’s clinical and research interests are in the areas of aortic valve and root disease, minimally invasive valve operations, complex reoperative heart surgery, health care quality and outcomes, and education for surgical teams.
As Program Director for Thoracic Surgery Residency and Advanced Fellowships, Dr Johnston oversees the largest training program for cardiothoracic surgeons in the US. He is a two-time recipient of the Bruce W Lytle Surgical Educator Award. In addition to training the next generation of surgeons, Dr Johnston is passionate about the importance of training medical teams to function well in situations of high stress and anxiety which are a necessary part of the practice of medicine. He collaborates with thought leaders from military special operations, sports, and the arts to re-imagine the training of 21st century leaders in surgery.
8:00AM - 9:30AM PDT Los Angeles Convention Center, 515A
Innovations in Heart Transplant and Assist Devices
Carmelo Milano, Duke University Medical Center
Dr. Carmelo A. Milano is currently a Professor of Surgery at Duke University in the Division of Thoracic and Cardiovascular Surgery. He is the Section Chief of Adult Cardiac Surgery and is the Surgical Director of the Left Ventricular Assist Device (LVAD) Program. He previously served as the Surgical Director for heart transplant at Duke for 18 years. He graduated with a BS degree from the University of Notre Dame in 1986, completed medical school at the University of Chicago, Pritzker School of Medicine in 1990, and General and Thoracic surgical training at Duke University in 1999. While in residency, he received the National Research Service Award from the NIH, the Dupont Young Investigators Award from the American College of Chest Physicians and the Pilling-Weck Young Investigators Award. He completed a Thoracic Transplantation Fellowship at Papworth Hospital in Cambridge, England. He joined the faculty at Duke in 1999. His basic research interest is gene therapy approaches to cardiovascular diseases. His clinical interests are in surgical treatments for advanced heart failure, including ventricular assist devices, valve repairs/replacements, coronary artery bypass grafting, hypertrophic cardiomyopathy, transplantation and ventricular remodeling procedures.
Michael Tong, Cleveland Clinic
Michael Zhen-Yu Tong, MD, MBA, FRCSC, is the Director of Cardiac Transplantation and Mechanical Circulatory Support and a staff cardiac surgeon at Cleveland Clinic. Dr. Tong has a wide clinical practice and performs around 350 cardiac cases annually including over 20 heart transplants, 30 ventricular assist devices, 50 aortic operations, 15 valve sparring root operations, 30 pulmonary endarterectomies and over 100 redo operations
Education and Training: Dr. Tong received his doctorate in medicine from McGill University, Montreal, Quebec, Canada. He served his residency in cardiac surgery at the University of Western Ontario, London, Ontario, Canada, and was Chief Resident in his final year of training. During his residency, he also completed a MBA at the Richard Ivey School of Business, London, Ontario. Dr. Tong completed his postdoctoral training at Cleveland Clinic in surgical heart failure and aortic surgery and was named to the Cleveland Clinic staff in 2014.
Publications and Speaking: Dr. Tong has authored or coauthored over 75 articles in peer-reviewed cardiovascular surgery journals and has coauthored many medical textbook chapters and delivers dozens of presentations in the US and internationally every year.
8:00AM - 9:45AM PDT Los Angeles Convention Center, 408B
Mesothelioma: Science and Advances*
Leah Backhus, Stanford Health Care, Stanford Medicine Children's Health, Stanford Health Care Tri-Valley
Leah Backhus, MD MPH FACS trained at the University of Southern California and the University of California Los Angeles. She is Associate Professor of Cardiothoracic Surgery at Stanford University and has grant funding through the Veterans Affairs Administration and the NIH. Her research examines imaging surveillance following treatment for lung cancer. She holds several leadership roles within the STS, AATS, and WTS also serves as Chair of the Women and Lung Cancer Task Group of the National Lung Cancer Roundtable of the American Cancer Society and Chair of the ACGME Thoracic Residency Review Committee.
Raphael Bueno, Brigham & Women's Hospital
Raphael Bueno, MD is the Chief of the Division of Thoracic and Cardiac Surgery, the Co-Director of the Lung Center and the Heart and Vascular Center and the Fredric G Levin Distinguished Chair of Thoracic Surgery and Lung Cancer Research at BWH. He is a Professor of Surgery at Harvard Medical School.
8:00AM - 9:30AM PDT Los Angeles Convention Center, 403B
Novel Strategies for Single Ventricle Management
Sitaram Emani, Boston Children's Hospital
Sitaram Emani is Associate Professor of Surgery at Harvard Medical School and Director of the Complex Biventricular Repair Program at Boston Children's Hosptial.
Aaron Eckhauser, Primary Children's Hospital
I am a pediatric cardiothoracic surgeon in Salt Lake City, Utah. I have focused my clinical and research work around pediatric health services, quality and outcomes research. Broadly, I have been interested in understanding the impact of metabolic and inflammatory derangements on clinical diseases, particulary in pediatric heart failure. I am currently studying universal pathogen detection and host immune transcriptomics using RNA-seq and a rapid genomic anlysis tool developed at the University of Utah, Taxonomer, to improve diagnosis of acute viral myocarditis in children. I am also heavily involved in pediatric outcomes research and I'm currently our center's surgical representative to the NHLBI-sponsored Pediatric Heart Network (PHN) study group. I have participated in multiple national collaborative research trials and writing groups focusing on practice variation surrounding the bidirectional Glenn and Fontan stages of single ventricle palliation. I serve as surgical lead for our Heart Center's quality improvement team and I also serve as the cardic representative for our hospital's surgical quality improvement team. We currently have 19 ongoing clinical quality improvement projects in our heart center. We have studied and developed a postoperative chyolothorax protocol in children undergoing cardiac surgery which has been implemented in an multi-institutional study through the Pediatric Cardiac Critical Care collaborative. Clinically, my area of focus is the aortic root in children, specifially the Ross operation. We will hosting an annual Ross training symposium in collaboration with Cedars Sinai hospital. Aditionally, I have developed a clinical interest in peripheral pulmonary artery reconstruction and other complex pulmonary artery reconstrcutions.
8:00AM - 9:30AM PDT Los Angeles Convention Center, 408A
Screening and Early Detection
Douglas Wood, University of Washington
Dr. Douglas E. Wood is The Henry N. Harkins Professor and Chair of the Department of Surgery at the University of Washington where he was previously Professor and Endowed Chair in Lung Cancer Research as well as the Chief of the Division of Cardiothoracic Surgery. Dr. Wood received his undergraduate and medical degrees from Harvard University and trained in General Surgery and Cardiothoracic Surgery at the Massachusetts General Hospital in Boston.
Dr. Wood is the Chair of the Lung Screening Guidelines Panel for the National Comprehensive Cancer Network (NCCN), Vice-Chair of the Non-Small Cell Lung Cancer Guidelines Panel for the NCCN, and Vice-Chair of the American Cancer Society National Lung Cancer Roundtable. Notably, Dr. Wood was the chair for the NCCN Lung Cancer Screening Panel which developed and published the first clinical guidelines for lung cancer screening. Dr. Wood helped lead an effort to change lung cancer screening policy at the national level, resulting in lung cancer screening recommendations from the United States Preventive Services Taskforce and from Medicare. Most recently, Dr. Wood has partnered in an international project led by the World Economic Forum and the Lung Cancer Collaborative to advance and prioritize lung cancer care worldwide, including broader utilization of early detection. This initiative is currently being evaluated by the World Health Organization for consideration of a global health priority, or “Best Buy”.
Dr. Wood served on the Board of Directors of the Society of Thoracic Surgeons for over 20 years, completing a 5-year term as Secretary of the Society, and was the President of STS in 2013 - 2014. Dr. Wood served as a Director of the American Board of Thoracic Surgery and as Chair of the ACGME Residency Review Committee Committee for Thoracic Surgery (RRC-Thoracic). Dr. Wood recently served as President of the Thoracic Surgery Foundation and President of the Cardiothoracic Surgery Network (CTSNet).
Betty Tong, Duke University Medical Center
Betty C. Tong, MD, MHS is an Associate Professor of Surgery at the Duke University Medical Center in Durham, North Carolina, USA. Her clinical interests are in lung cancer screening, surgical management of thoracic malignancies such as lung cancer and soft tissue sarcoma of the chest, and video assisted thoracic surgery. Her research interests are centered in the area of health services research, and include the study of disparities in thoracic surgical patients, and patient preferences and decision making in the management of thoracic disease.
8:00AM - 9:30AM PDT Los Angeles Convention Center, 502A
Seeing is Believing: Unique Cardiac Case Videos
Vinay Badhwar, West Virginia University
Dr. Vinay Badhwar is the Gordon F. Murray Professor and Chairman of the Department of Cardiovascular and Thoracic Surgery of West Virginia University, and the Executive Chair of the WVU Heart and Vascular Institute and Service Line based in Morgantown, West Virginia, USA. He is an author of over 300 peer-reviewed publications and he serves as the Associate Editor of the Journal of Cardiovascular and Thoracic Surgery.
Dawn Hui, University Hospital
Dawn Hui, Associate Professor of Cardiothoracic Surgery at UT Health San Antonio, is an adult cardiac surgeon with a clinical focus on aortic surgery, multi-arterial coronary bypass grafting, and structural heart interventions. A board-certified cardiothoracic surgeon, Dr. Hui obtained her medical degree and general surgery residency at The University of Texas Southwestern Medical Center, followed by cardiothoracic surgical training at The University of Southern California. She also serves as Associate Program Director of the Thoracic Surgery Residency program and is the faculty advisor for the CT Surgery Interest group at the School of Medicine. Her research interests include clinical outcomes and translational research.
Dr. Hui is on the Editorial Boards of The Journal of Thoracic and Cardiovascular Surgery and Annals of Thoracic Surgery.
8:00AM - 9:30AM PDT Los Angeles Convention Center, 406AB
Surgical Ethics I: The Physician - Patient Relationship
Kathleen Fenton, National Heart, Lung, and Blood Institute
Dr. Kathleen Fenton is a congenital heart surgeon and bioethicist, and is currently the Chief of the Advanced Technologies and Surgery Branch at the National Heart, Lung, and Blood Institute (NHLBI).
After completing her training in congenital heart surgery, Dr. Fenton had two academic positions as a surgeon in the U.S., where she trained students and residents and did research in fetal heart surgery. In 2006, she moved to Managua to help establish a pediatric heart surgery program. Her intention was to return home after two or three years of humanitarian work, but the work was immensely rewarding. She quickly realized that she was not only giving life back to children who otherwise would have no access to surgery, but that by mentoring the local surgeon and medical team she was allowing them to develop their careers in a way that would not have otherwise been possible. She spent a total 12 years doing full time global surgery, working in Ukraine, Libya, and Nigeria in addition to several Latin American countries.
Meanwhile, when she was appointed to serve on the Standards and Ethics Committee for the Society of Thoracic Surgeons in 2010, Dr. Fenton soon realized just how great a need there is for surgeons to be actively involved in bioethics! This motivated her to obtain formal training in bioethics.
Dr. Fenton oversees a branch that manages portfolios in bioengineering, imaging, data science and regenerative medicine, serves as the science officer for the Cardiothoracic Surgical Trials Network, collaborates on many committees and projects across NHLBI and NIH, and is an Affiliate Scholar in NIH’s Department of Bioethics.
9:45AM - 11:30AM PDT Los Angeles Convention Center, 406AB
AATS/WTS DEI: Bridging the Gap in CT Surgery | In Collaboration with AATS and WTS
Daniela Molena, Memorial Sloan Kettering Cancer Center
Dr. Daniela Molena is an Associate Professor of Surgery at Weill Cornell Medicine and Associate Attending and Director of the Esophageal Program at Memorial Sloan Kettering Cancer Center (MSKCC). She is the Chair of the Thoracic Education Committee with the AATS, a Member of the AATS Thoracic Quality Committee and a Member of the Board of Directors of the AATS Foundation. She is also the Vice President of the Women in Thoracic Surgery and a Councilor of the Southern Thoracic Surgical Association. Dr Molena is a Deputy Editor for the Annals of Thoracic Surgery and associate Editors for Disease of the Esophagus. She serves in numerous national and international committees related to esophageal and thoracic surgery.
Lauren Kane, Children's Hospital New Orleans
Lauren Kane, MD is a congenital cardiac surgeon and is passionate about the care of adult congenital and pediatric heart problems. She currently serves as President of the Women in Thoracic Surgery. She is committed to increasing diversity, inclusion, equity and mitigating bias in the field of cardiothoracic surgery. She is an active sponsor of colleagues and provides mentorship to men and women alike in cardiothoracic surgery and life. She is well published and very active on the national level with various leadership positions in cardiothoracic surgery.
9:45AM - 11:30AM PDT Los Angeles Convention Center, 515B
Advanced Aortic Root Surgery*
Hans-Joachim Schäfers, UKS Saarland
Born in 1957. Residency training under Prof. H. Borst, fellowship at the University of Toronto (thoracic surgery).
Since 1995 Professor of Surgery and Director of the Department of Thoracic and Cardiovascular Surgery, Saarland University Medical Center in Homburg/Saar, Germany.
Focus areas: aortic valve repair, Ross operation, aortic surgery, pulmonary endarterectomy.
> 500 scientific publications
Elaine Tseng, UCSF and SFVA
Dr. Tseng is Professor of Surgery at the University of California San Francisco and Chief of Cardiothoracic Surgery at the San Francisco VA. Her academic research interests over the past 19 years have involved biomechanics, fluid dynamics, and computational simulations of aortic root surgery, including aortic stenosis, transcatheter aortic valves, Ross operation, ascending thoracic aortic aneurysm (aTAA) and dissection. She has been an NIH R01 funded surgeon-scientist investigating the biomechanics of ascending thoracic aortic aneurysms to determine better predictors of type A dissection than maximum diameter. Through the VA, she will investigate the impact of aTAA biomechanics on dissection, rupture, and death. Her clinical expertise is in structural heart disease and aortic surgery, including transcatheter aortic valve replacement, mitraclip, minimally invasive surgical valve repair and replacement, and ascending thoracic aneurysm repair. She has published >100 scientific papers and book chapters. Dr. Tseng serves on the Society of Thoracic Surgeons (STS) Workforce for New Technology and Workforce on Health Policy, Advocacy, & Reform, American Association for Thoracic Surgery (AATS) Research Foundation, and American Heart Association (AHA) Cardiovascular Surgery and Anesthesia Council. She is completing her tenure as the Chair of the Thoracic Surgery Foundation Research Committee.
9:45AM - 11:30AM PDT Los Angeles Convention Center, 515A
Complex Issues in Coronary Surgery*
Aya Saito, Toho University Sakura Medical Center
Dr Saito studied medicine at Yokohama City University School of Medicine. During her fourth year at medical school lecture on artificial organ and cardiac transplantation inspired her and she discovered her passion for heart surgery. After completing her general, thoracic, and cardiac surgery training in Yokohama, she moved to Tokyo and practiced adult cardiac, pediatric cardiac and vascular surgery at the University of Tokyo, Faculty of Medicine. In 2002, she entered to postdoctoral course to earn PhD, and made several basic and clinical investigations on cryopreserved heart-valve and vascular allograft and completed her work. She became a staff surgeon at the University of Tokyo and worked in adult cardiac surgery area in 2006. In the same year she founded Women in Thoracic Surgery (WTS) in Japan with a great support by Women in Thoracic Surgery (USA). In 2007, she joined the clinical fellowship at Division of Cardiac Surgery and Multi Organ Transplant Unit, London Health Sciences Centre, University of Western Ontario, Canada and spent her passion on clinical & basic practice on cardiac transplantation as well as adult cardiac surgery including minimally invasive and robotic surgery. She came back to the University of Tokyo in 2009 and started as assistant professor at Department of Cardiothoracic Surgery and became lecturer in 2011. In 2014 she moved to Toho University Sakura Medical Center as associate professor at Division of Cardiac Surgery and also director of Division of Medical Engineering. She has been organizing annual meetings for Women in Thoracic Surgery in Japan since 2006, serving herself to promote mentor-mentee relationship among both female and male surgeons across the country. She serves on several national/international profession organization committees and boards. Today she serves herself energetically for a full spectrum of adult cardiac surgical care, and also enjoys the privilege of teaching the next generation of cardiac surgeons.
Todd Rosengart, Baylor St. Luke's Medical Center
Dr. Todd K. Rosengart is professor and chair of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine. He is the DeBakey-Bard Chair of Surgery and is professor of heart and vascular disease at the Texas Heart Institute. He is past president of the Society of Surgical Chairs and a member of the board of directors of the American Association for Thoracic Surgery.
Dr. Rosengart continues to run an NIH-funded laboratory with over 20 years of NIH support in the fields of angiogenesis and cellular reprogramming. In 1997, he and his team at Cornell performed the world’s first viral-based cardiac gene transfer procedure, part of a landmark NIH and FDA-approved first-in-man angiogenesis trial for “no option” patients with end stage coronary artery disease. He is PI of a cardiovascular surgery NIH T32 training grant, recipient of $20 million in total research grants, holds thirteen U.S. patents and is author of over 200 peer-reviewed articles and other publications with an h-index of 60. He has mentored nearly 100 research and cardiac surgery trainees over the past 30 years.
Dr. Rosengart is past chair of the NIH Bioengineering, Technology and Surgical Sciences Study Section, chair of a new American College of Surgeons National Surgeon Scientist Study Section and a member of the Scientific Advisory Committee for the Leducq Foundation. He was editor of Seminars in Thoracic and Cardiovascular Surgery from 2013 to 2020. Amongst other affiliations, he is a member of the American Surgical Association, the Southern Surgical Society, the Society of Thoracic Surgeons, the Southern Thoracic Surgical Society and the Texas Surgical Society.
Dr. Rosengart is co-founder of Vitals.com (MDx, LLC), a web-based medical consumerism and physician search company and co-founder of XyloCor Therapeutics, a gene therapy company leading an FDA Fast Track designated Phase I/II national trial of angiogenic gene therapy for treating patients with end stage coronary artery disease.
9:45AM - 11:30AM PDT Los Angeles Convention Center, 502A
Complex Solutions for Mitral and Tricuspid Valve Disease
Richard J. Shemin, Ronald Reagan UCLA Medical Center
The Robert and Kelly Day Chair in Cardiothoracic Surgery is held by Richard Shemin, M.D., Chief of the Division of Cardiac Surgery, vice chair of the Department of Surgery, and a Distinguished Professor at the David Geffen School of Medicine. Dr. Shemin is a distinguished leader in the field of cardiothoracic surgery. He has held roles as Chair of The American Board of Thoracic Surgery, Director of the Society of Thoracic Surgeons, the American Association of Thoracic Surgery, and Governor of the American College of Surgeons. He is the current President of the Board of the Greater Los Angeles Chapter of the American Heart Association. As a pioneer of less invasive procedures for aortic valve replacement, aortic aneurysm replacement and robotic mitral valve repair, Dr. Shemin has been crucial to the growth of UCLA’s reputation as a world-renowned cardiothoracic surgery center. As the Program Director for the ACGME Cardiothoracic Residency Program, he is committed to training the next generation of cardiothoracic surgeons. He has received several teaching awards. Recently he was inducted into the prestigious American College of Surgeons Academy of Master Surgeon Educators.
Joanna Chikwe, Cedars-Sinai Medical Center
Dr. Chikwe is Chairman of the Department of Cardiac Surgery and the Irina and George Schaeffer Distinguished Chair in Cardiac Surgery at Cedars-Sinai, Los Angeles which is currently ranked by U.S News and World Report among the top 3 programs nationally, thanks to deep expertise in heart and lung transplantation, structural heart, and robotic cardiac surgery. Dr. Chikwe’s clinical focus is robotic mitral valve repair.
Editor-in-Chief of The Annals of Thoracic Surgery, Dr. Chikwe’s research encompasses the interface between interventional and surgical therapies for valvular heart and coronary artery disease, with over 250 peer reviewed publications including contributions in The New England Journal of Medicine andThe Journal of the American Medical Association (JAMA). She is Principal Investigator of the NHLBI pivotal randomized trial of Percutaneous or surgical Repair In Mitral prolapse And Regurgitation in patients >65 Years PRIMARY trial ( NCT05051033) sponsored by the Cardiothoracic Surgical Trials Network.
9:45AM - 11:30AM PDT Los Angeles Convention Center, 408B
Lung Cancer: The Important Multidisciplinary Role of Thoracic Surgeons
Ravi Rajaram, University of Texas MD Anderson Cancer Center
Ravi Rajaram, MD MSc FACS, is currently an Assistant Professor in the Department of Thoracic and Cardiovascular Surgery at the University of Texas MD Anderson Cancer Center. Dr. Rajaram completed his residency training in General Surgery at Northwestern University in Chicago, IL. During residency, Dr. Rajaram served as an American College of Surgeons Clinical Scholar-in-Residence, completed a postdoctoral fellowship on a T32 Health Services Research Training Program, and earned a Master’s degree in Health Services and Outcomes Research at Northwestern University. Dr. Rajaram completed a fellowship in Cardiothoracic Surgery at the MD Anderson Cancer Center / Memorial Hermann.
Dr. Rajaram is certified by the American Board of Surgery and American Board of Thoracic Surgery. His clinical interests include all aspects of thoracic surgical oncology with a particular interest in utilizing minimally-invasive approaches to surgical care. He serves as the Clinical Medical Director of the Thoracic Center at MD Anderson and continues to engage in clinical and health services research.
Frank Detterbeck, Yale-New Haven
Frank Detterbeck MD, New Haven, Connecticut, USA
I am a Professor of Thoracic Surgery, and served as Chief of Thoracic Surgery and Director of the Thoracic Oncology Program at the Yale Cancer Center until recently. I have been very active in thoracic oncology and thoracic surgery for over 25 years. I am the Chair of the Lung Cancer Guidelines of the American College of Chest Physicians, and have been active in most of the professional organizations in thoracic oncology and thoracic surgery. I have edited 11 textbooks on lung cancer, mediastinal malignancies and thoracic surgery, and have written more than 350 peer reviewed journal articles and 60 book chapters.
9:45AM - 11:30AM PDT Los Angeles Convention Center, 403B
Strategies for the Failing Ventricle
Michael Ma, Lucile Packard Children's Hospital
Michael Ma, MD is an Assistant Professor of Cardiothoracic Surgery in the Division of Pediatric Cardiac Surgery at Stanford University. His clinical practice encompasses all aspects of congenital heart disease, with an emphasis on complex reconstructive procedures for achieving biventricular circulation, rehabilitating pulmonary artery pathologies, and device therapy for end-stage heart failure. He serves as the Surgical Director for the Complex Biventricular Reconstruction and Pediatric Advanced Cardiac Therapies programs.
Dr. Ma’s translational research utilizes biomechanical engineering principles to optimize existing treatments and develop new procedures and therapies, through collaborations between the Schools of Medicine and Engineering. His lab focuses on understanding the atrioventricular valve in single and complex biventricular circulations; de novo surgical repair strategies and devices are evaluated in ex vivo and large animal models.
David Morales, Sr.
David Luís Simón Morales, M.D. is Executive Co-Director of Cardiothoracic Surgery at Cincinnati Children’s Hospital Medical Center. Dr. Morales is a Professor of Pediatrics and Surgery and is the James S Tweddell Endowed Chair of Pediatric Cardiothoracic Surgery. He completed his undergraduate education at Duke University, going on to medical school at Yale University and completed his general surgery and cardiothoracic residency at New York Presbyterian Hospital (Columbia University). He went to Texas Children’s Hospital in 2004 to be the Emmett Augustus Jones Congenital Heart Surgery fellow. He remained on staff there for 9 years before going to Cincinnati Children’s Hospital. He has an active research lab ranging from 2 RO-1 Grants in Re-Vamping Transplant Allocation using AI and Anti-cagulation/inflammation with mechanical devices, to tissue engineering, and virtual surgery. His clinical interests include biventricular repairs in Heterotaxy Syndrome, complex neonatal surgery, mechanical circulatory support and the failing Fontan Circulation. Dr. Morales has contributed 350 manuscripts (H-index 53) and > 30 book chapters/reviews to the medical literature, has had 350 abstracts accepted to academic meetings, and has given >280 lectures nationally and internationally. He is on the editorial board of 5 journals (i.e. Annals of Thoracic Surgery, Journal of Thoracic and Cardiovascular Surgery, Journal of Heart and Lung Transplantation). Because of his interest in quality improvement and outcome databases at a local and national level, he has been asked to serve as the Director of Outcomes and Quality for the Department of Surgery at Cincinnati Children’s Hospital.
9:45AM - 11:30AM PDT Los Angeles Convention Center, 409AB
Updates in Cardiothoracic ERAS
Subhasis Chatterjee, Baylor St. Luke's Medical Center
Dr. Chatterjee is a cardiovascular surgeon and intensivist at Baylor St Lukes Medical Center/Texas Heart Institute and an Associate Professor of Surgery at the Baylor College of Medicine. He serves as the Thoracic Surgical ICU and ECMO Program Director of one of the nation's busiest adult ECMO programs. His clinical interests include perioperative care after aortic surgery, mechanical circulatory support, and machine learning/decision support in perioperative care. He is an Executive Board member of the Enhanced Recovery After Surgery-Cardiac Surgical Society and has lectured extensively on ERAS topics. He has authored over 110 peer-reviewed manuscripts and serves on the editorial board of the Journal of Thoracic and Cardiovascular Surgery.
Dao Nguyen, The University of Miami Health System
Doctor Nguyen obtained his medical degree at McGill University, Montreal QC Canada in 1986 (MDCM) He completed general surgery and cardiothoracic surgery residencies at the same institution in 1992 and 1994 respectively. He completed a research/clinical super fellowship in thoracic oncology at MD Anderson (1996). He is board-certified in Thoracic Surgery by the Royal College of Surgeons of Canada and b the American Board of Thoracic Surgery. After a short stay at McGill University (1996-1998) as a junior faculty member of the division of CT surgery, Dr Nguyen was recruited to join Dr David Schrump of the Section of Thoracic Surgery, Surgery Branch (NCI/NIH) where he remained for 9 years as senior investigator (1998-2007). He resumed the position of chief of thoracic surgery at the University of Miami (2007) until the present time. He currently holds the B. and Donald Carlin Endowed Chair of Thoracic Surgical Oncology. The focus of Dr Nguyen clinical research is the implementation of Enhanced Recovery after Surgery for thoracic patients and quality improvement process to achieve minimal postoperative pain and opioid utilization after thoracic surgical procedures. His clinical interest is minimally invasive thoracic surgery particularly robotic thoracic operations as well as clinical outcomes of patients undergoing pulmonary resection for primary lung cancer especially in the “enhanced recovery” era and following “textbook oncology practice leading to textbook oncology outcomes”.
9:45AM - 11:30AM PDT Los Angeles Convention Center, 408A
What's New in Thoracic Transplant?
Konrad Hoetzenecker, General Hospital Vienna
Konrad Hoetzenecker, MD PhD is a member of the surgical faculty of the Department of Thoracic Surgery, Medical University of Vienna, and the Director of the Vienna Lung Transplant Program. Besides lung transplantation he is specialized in airway surgery and extended thoracic procedures. Dr Hoetzenecker has authored numerous peer-reviewed articles and is an editorial board member of the Journal of Thoracic and Cardiovascular Surgery and the Journal of Heart and Lung Transplantation. Dr Hoetzenecker has been awarded several prizes and grants including the Graham Memorial Traveling Fellowship from the American Association of Thoracic Surgery.
Christine Lau, University of Maryland Medical Center
Dr. Christine L. Lau, MBA is the Dr. Robert W. Buxton Chair of the Department of Surgery at the University of Maryland School of Medicine and the Chief of Surgery at the University of Maryland Medical Center. She specializes in all aspects of general thoracic surgery including lung cancer, mediastinal diseases, benign lung and esophageal disease, esophageal cancer and lung transplantation. Dr. Lau is board certified in general and thoracic surgery. Dr. Lau received her medical degree from Dartmouth Medical Center in Hanover, NH. She received numerous awards while she was there, including being elected to Junior AOA and receiving the Janet M. Glasgow Memorial Award for graduating 1st in her medical school class. She subsequently did her internship and residency in general surgery at Duke University Medical Center in Durham, NC. After completing her general surgery training, she went to Washington University in St. Louis, one of the premier lung transplant programs in the world and spent a year doing a lung transplant fellowship, as well as her fellowship in cardiothoracic surgery which she subsequently finished in 2005. Dr. Lau had an academic appointment at the University of Michigan Medical Center in Ann Arbor, MI as an Assistant Professor of Surgery prior to joining the University of Virginia. She has consistently been voted a Top Doctor in Thoracic Surgery and Cancer. In 2006, she was awarded the John Kirklin Fellowship given by the AATS. In 2008, she was awarded a K08 from the NIH to study mechanisms of chronic rejection in lung transplants. In 2015 she received a R01 from the NHLBI to continue her research in lung transplantation. Dr. Lau serves on numerous national committees and boards, including being a Director of the ABTS, a Director for the AATS, and a member of the Leapfrog Expert Panel. She is also is a member of the Surgery, Anesthesia, and Trauma Study Section at the NHLBI.
11:30AM - 1:15PM PDT Los Angeles Convention Center, 502B
C. Walton Lillehei Resident Forum: Honorable Mention Rapid Fire Orals
Christopher Seder, Rush University Medical Center
Dr. Seder is the Arthur E. Diggs, MD and L. Penfield Faber, MD Chair of Surgical Sciences and Chief of Thoracic Surgey at Rush University Medical Center. His academic interests include investigating blood-based tumor markers to identify lung cancers at the earliest stage, outcomes research, and resident education. Dr. Seder is also the cardiothoracic surgery residency program director and has been awarded the L. Penfield Faber Teaching Award for excellence in education multiple times.
Sandra Starnes, University of Cincinnati Medical Center
Dr. Starnes is a Professor of Srugery and tthe John B. Flege Chair of Cardiothoracic Surgery at the University of Cincinnati She is also the Program Director for the Integrated Thoracic Surgery Residency.
She is a general thoracic surgeon wtih expertise in thoracic malignancies, including lung cancer, esophageal cancer and mediastinal tumors, with a focus on minimally-invasive and complex thoracic procedures. She is the Director of the University of Cincinnati Lung Cancer Center.
She has been active in multiple national organizations. She has served as President of the Thoracic Surgey Directors Assocation. She has been a quest examiner for the American Board of Thoracic Surgery since 2013 and currently serves on the Thoracic Surgery Residency Review Committee.
12:00PM - 1:00PM PDT Los Angeles Convention Center, Room 403B
12:00PM - 1:00PM PDT Los Angeles Convention Center, Room 406AB
12:00PM - 1:00PM PDT Los Angeles Convention Center, Room 515A
1:15PM - 5:00PM PDT Los Angeles Convention Center, West Hall B
Yolonda Colson, Massachusetts General Hospital
Dr. Colson is the current President of the American Association for Thoracic Surgery, having served in many roles since becoming a member in 2003, including as Co-chair of the 2015 Annual Meeting and Chair of the Advisory Council for the AATS Foundation. She is the Chief for the Division of Thoracic Surgery at Massachusetts General Hospital and Hermes C. Grillo Professor of Surgery at Harvard Medical School. In addition to her cardiothoracic surgical training at Brigham and Women’s Hospital, her academic training includes a B.S. in Biomedical Engineering from Rensselaer Polytechnic Institute, an M.D. from Mayo Medical School, and a Ph.D. and general surgery residency at University of Pittsburgh. Career awards include: the inaugural Michael A. Bell Family Chair in Healthcare Innovation, the George H.A. Clowes, Jr. Research Career Development Award from the American College of Surgeons, the Edward M. Kennedy Award for Health Care Innovation, and serving as the Exam Chair of the American Board of Thoracic Surgery from 2017-2021. She is the current PI/co-PI on five NIH R01/U01 Grants and has recently been elected to the National Academy of Medicine.
She is co-inventor on three awarded patents and has received over twenty grants including the AATS Alton Ochsner Research Scholarship and eight "R" or "U" grants from the National Institutes of Health and National Cancer Institute. Dr. Colson's research focuses on the development of unique mechanisms of polymer and nanoparticle drug delivery aimed at preventing cancer recurrence, and the investigation of novel methods to identify hidden tumor that has spread to nearby lymph nodes. She has over 150 peer reviewed publications highlighting her previous work in transplantation and her most recent investigations in sentinel lymph nodes in lung cancer and polymer-mediated drug delivery. She has formally mentored well over 30 students, residents and junior faculty since becoming an attending thoracic surgeon.
Rosemary Kelly, University of Minnesota Medical Center
Rosemary Kelly, MD currently serves as the Secretary of the AATS. She is the C. Walton and Richard C. Lillehei Professor and Executive Vice-Chair of Cardiovascular and Thoracic Surgery at the University of Minnesota. She completed medical school at the University of Chicago, Pritzker School of Medicine and General surgery training at Los Angeles County/University of Southern California Medical Center. She completed Thoracic surgery residency at the University of Minnesota and joined the faculty of the Cardiothoracic Surgery Division. She is Program Director of the Thoracic Surgery Residency and Vice-Chair of Clinical Faculty Development for the Department of Surgery at the University of Minnesota. In addition, she is Chief of the Heart and Vascular Service Line for M Health Fairview.
Dr. Kelly is actively involved in basic and translational research. Her basic science work uses in vitro and in vivo models of chronically ischemic myocardium to study molecular and physiologic recovery following revascularization as well as in response to cell based reparative therapies. Clinically, she has been involved in numerous trials in coronary revascularization and lung transplantation. She participated in the CARP, RAVE, REGROUP, and VALOR trials, serving on the Executive Committees for RAVE and REGROUP. She also participated in ex vivo lung organ preservation INSPIRE and EXPAND trials. For the AATS, Dr. Kelly has served on the Membership Committee for 6 years and as Chair for two years. She is a current member of the AATS Foundation Board, the Leadership Academy Board, Publications Committee and Cardiothoracic Residents Committee. In these roles, she strives to improve educational experiences and professional opportunities for the next generations of cardiothoracic surgeons.
5:00PM - 5:45PM PDT Los Angeles Convention Center, Tech Theater 1, Exhibit Hall
General Thoracic Biology Club Scientific Session | at the Welcome Reception*
Daniel Kreisel, Barnes Jewish Hospital
Daniel Kreisel MD PhD is a tenured Professor of Surgery, Pathology & Immunology at Washington University in St. Louis. He holds the G. Alexander Patterson MD / Mid-America Transplant Endowed Chair in Lung Transplantation, serves as the Surgical Director of the Lung Transplant program and the Scientific Director of the Transplant Center. He obtained his MD from Mount Sinai School of Medicine and a PhD in Immunology from The University of Pennsylvania. He completed his training in Surgery at The Hospital of The University of Pennsylvania and his training in Cardiothoracic Surgery at Washington University in St. Louis. His research laboratory at Washington University in St. Louis studies transplantation immunology with a particular focus on mechanisms that mediate ischemia reperfusion injury after heart and lung transplantation as well as mechanisms that regulate rejection and tolerance after lung transplantation. His research program has been supported by grants from The National Institutes of Health (National Institutes of Allergy and Infectious Diseases & National Heart, Lung, and Blood Institute), The Department of Veterans Affairs, The Cystic Fibrosis Foundation and The Foundation for Barnes-Jewish Hospital. Dr. Kreisel has published over 280 peer reviewed manuscripts and is currently a Deputy Editor for The American Journal of Transplantation. He is an elected member of The American Society for Clinical Investigation, The American Surgical Association and The Association of American Physicians.
Mark Onaitis, University of California San Diego
Mark Onaitis is Professor of Surgery and the Sheri Kelts Chair in Cardiothoracic Surgery at the University of California, San Diego.
6:00PM - 7:00PM PDT Los Angeles Convention Center, Tech Theater 1, Exhibit Hall
AATS Cardiothoracic Resident Case Report Competition | at the Welcome Reception
Nahush Mokadam, The Ohio State University Wexner Medical Center
Dr. Nahush A. Mokadam is the Division Director of Cardiac Surgery at The Ohio State University Wexner Medical Center, where he holds the Kakos and Williams Endowed Professorship in Cardiac Surgery. His clinical expertise includes all aspects of adult cardiac surgery, including minimally invasive valve repair and replacement, all-arterial revascularization, heart and lung transplantation, mechanical circulatory support and aortic root reconstruction. He is internationally recognized as a leader in total artificial heart implantation. Dr. Mokadam has been an avid participant in novel national and international clinical trials, especially in the field of advanced heart failure and minimally invasive LVAD implantation. He collaborates closely with basic scientists and biomedical engineers to promote ground-breaking translational research, resulting in one of the highest NIH-funded Divisions of Cardiac Surgery in the country. Dr. Mokadam also has extensive experience in surgical education, with a focus on high fidelity surgical simulation. He is the Program Director of the integrated six-year cardiothoracic residency program and is committed to developing the next generation of cardiothoracic surgeons while advancing opportunities for women and minorities to pursue careers in cardiothoracic surgery. Under his leadership, the Division of Cardiac Surgery at The Ohio State University Wexner Medical Center has seen a substantial growth in patient volume, an improvement in quality metrics, a rejuvenation of collaborative culture, and a commitment to diversity and inclusion.
Stephanie Fuller, Children's Hospital of Philadelphia
Stephanie Fuller, MD, MS, is a Professor of Clinical Surgery in the Division of Cardiothoracic Surgery at Children’s Hospital of Philadelphia (CHOP) and the Hospital of the University of Pennsylvania. Dr. Fuller performs the full range of reconstructive congenital operations, as well as cardiothoracic transplantation, in neonates to adults. She is the Thomas L. Spray, MD Endowed Chair in Pediatric Cardiothoracic Surgery at CHOP and the Surgical Director of the Philadelphia Adult Congenital Heart Center, a joint program of CHOP and Penn Medicine for adult survivors. Dr. Fuller is the Program Director of Congenital Cardiothoracic Fellowship at the Children’s Hospital of Philadelphia. She is an Associate Editor for the Journal for Thoracic and Cardiovascular Surgery, Congenital CME Editor for The Annals of Thoracic Surgery and an oral board examiner for the American Board of Thoracic Surgery. She is the Congenital Committee Chair for the Thoracic Surgery Directors Association. Her research focuses upon long term outcomes of single ventricle disease, neurocognitive outcomes after congenital heart surgery, and adult congenital heart disease issues such as prosthetic valve longevity in young adults and combined heart liver transplantation for single ventricle patients. Dr. Fuller lectures internationally and has published numerous peer-reviewed articles in such journals as The Annals of Thoracic Surgery and The Journal of Thoracic and Cardiovascular Surgery.
Bradley Taylor, University of Maryland Medical Center
Bradley Taylor, MD, MPH, is Professor and Chief, Division of Cardiac Surgery at The University of Maryland School of Medicine. He also serves as the Director of Coronary Revascularization and the Co-Director of the Center of Aortic Disease.
Dr. Taylor graduated from Oxford College of Emory University and Emory College with a Bachelor of Science in Biology. He received his Master’s in Public Health with a focus in Health Administration and a Medical Degree from the Emory University School of Medicine. Dr. Taylor trained in both general and cardiothoracic surgery at the University of Pittsburgh Medical Center. There he studied the regulation and expression of the Human Inducible Nitric Oxide Synthase (INOS) Gene. He has published manuscripts in both the Proceedings of National Academy of Science and the Journal of Biochemistry. After training, Dr. Taylor stayed at the University of Pittsburgh Medical Center as an Assisted Professor in Cardiothoracic.
In 2006, Dr. Taylor completed a minimally invasive mitral valve cardiac surgery fellowship at the OLV Hospital in Aalst Belgium
Dr. Taylor joined the faculty at the University of Maryland School of Medicine in 2012, after establishing a busy community-based practice in Cardiac and Vascular surgery in South Central PA. His clinical and research efforts have focused on the surgical treatment of aortic disease, coronary artery bypass grafting as well as the impact of cardiac surgery in the state of Maryland. He performs over 400 complex adult cardiac cases per year and leads a Cardiac Surgery team that performs more than 1800 cardiac operations per year. Dr. Taylor performs a full array of cardiac surgery and has been instrumental in developing and implementing an advanced endovascular aortic repair program.
Dr. Taylor was appointed Chief of the Division in 2021. Through his and his team's efforts, Maryland is now a leader in quality outcomes and market shares.
Anelechi Anyanwu, Mount Sinai Health System
Dr. Anyanwu is Professor and Vice-Chairman of the Department of Cardiovascular Surgery in the Icahn School of Medicine at Mount Sinai. His clinical interests include mitral valve surgery, reoperative surgery, and surgery for heart-failure. Dr. Anyanwu has served the AATS in various roles, including serving on the Program Committee for prior Mitral Conclave and Annual Meetings. He currently serves on the AATS Board.
7:15PM - 8:30PM PDT JW Marriott L.A. Live, Platinum Ballroom F-G, JW Marriott Hotel
No added events available on this day